Prostate-Specific Antigen(PSA) Monoclonal Antibody

Background:
PSA is a kind of glycoprotein synthesized by prostatic epithelial cells. At present, it is considered to be one of the specific tumor markers, which is mainly used in the judging of prostate cancer and metastatic prostate cancer, but it can not be used as the differential judging of benign and malignant prostate diseases. Because, the vast majority of prostatic hyperplasia epithelium are positive.

Location: CytoplasmP07288TBS with 0.1% Proclin300, PH7.4

Concentration: 100 μg/mL for the RTU antibody, 1mg/mL for the concentrated antibody